🇺🇸 Oral micronized progesterone in United States
5 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 5
Most-reported reactions
- Drug Ineffective — 1 report (20%)
- Hot Flush — 1 report (20%)
- Insomnia — 1 report (20%)
- Middle Insomnia — 1 report (20%)
- Product Substitution Issue — 1 report (20%)
Frequently asked questions
Is Oral micronized progesterone approved in United States?
Oral micronized progesterone does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Oral micronized progesterone in United States?
University of British Columbia is the originator. The local marketing authorisation holder may differ — check the official source linked above.